Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
in2cure has raised SEK 10 million in venture capital from private investors. The company, a member of SmiLe Incubator in Lund, is developing a gel to promote wound healing based on research at Lund University. in2cure is now accelerating development and plans to initiate clinical studies at the end of 2019. Helene Hartman, previously a member of the board of directors, is taking over as the new CEO.
The Norwegian pharmaceutical manufacturer Curida has attracted yet another strong private investor. Stokke Industri AS joins the Curida team along with Canica, Klaveness Marine and Investinor. Curida has now raised more than 100 million NOK from external investors.
Are you and your cluster company in need of early stage funding? Apply forInnovasjonsrammen by the 10th of September and compete for important start-up money.
Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to USD 8.8 billion.